Skip to main content

Table 2 Information of each patient in refractory group

From: Topical applications of allogeneic adipose-derived mesenchymal stem cells ameliorate the canine keratoconjunctivitis sicca

Age

Gender

Breed

STT

TBUT

Previous treatment / period

OD

OS

OD

OS

1

IF

Yorkshire terrier

10

–

3

–

2% CsA / 1Y

6

NM

mixed

17

21

11

9

2% CsA / 5Y

14

NM

Miniature dachshund

8

3

3

3

1% CsA / 3Y

5

NF

Pug

0

11

0

3

1% CsA / 4 M

14

NM

Yorkshire terrier

0

0

0

3

2% CsA / 2Y; TA / 1Y

8

NF

Maltese

0

3

3

5

TA / 1Y

9

NF

Maltese

0

4

2

2

TA / 3Y

10

NF

Maltese

15

5

3

3

1% CsA / 2Y

8

NM

King Charles Spaniel

0

0

3

0

Optimmune / 1Y

13

NM

Chihuahua

0

18

0

3

1% CsA / 2Y; TA/2 M

9

NF

Miniature dachshund

0

0

3

2

1% CsA / 3Y

9

NF

Miniature poodle

10

5

1

2

TA / 4Y

  1. NM neutered male, NF neutered female, IM intact male, IF intact female, OD oculus dextrus, OS oculus sinister, CsA Cyclosporine A, TA Tacrolimus, Y years, M months